UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin‐3 level

Journal of diabetes investigation, 2020-09, Vol.11 (5), p.1295-1302

2020

Volltextzugriff (PDF)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR

Diabetes, metabolic syndrome and obesity, 2019-08, Vol.12, p.1543-1553

2019

Volltextzugriff (PDF)

Association of Obesity based on Different Metabolic Status with Risk of Gout Occurrence in Patients: A National Study

Endocrine, metabolic & immune disorders drug targets, 2024-01, Vol.24 (8), p.973-980

2024

Volltextzugriff (PDF)

The effect of G0S2 on insulin sensitivity: A proteomic analysis in a G0S2 -overexpressed high-fat diet mouse model

Frontiers in endocrinology (Lausanne), 2023-03, Vol.14, p.1130350-1130350

2023

Volltextzugriff (PDF)

The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP/PS1 mice

Journal of translational medicine, 2023-09, Vol.21 (1), p.1-657, Article 657

2023

Volltextzugriff (PDF)

Thyrotropin and obesity: increased adipose triglyceride content through glycerol-3-phosphate acyltransferase 3

Scientific reports, 2015-01, Vol.5 (1), p.7633-7633, Article 7633

2015

Volltextzugriff (PDF)

Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Gynostemma pentaphylla (Thunb.) Makino treated mice

Nutrition & metabolism, 2018-12, Vol.15 (1), p.86-86, Article 86

2018

Volltextzugriff (PDF)

Exploring the link between obesity and hypothyroidism in autoimmune thyroid diseases: a metabolic perspective

Frontiers in molecular biosciences, 2024-04, Vol.11, p.1379124-1379124

2024

Volltextzugriff (PDF)

Single-Cell Sequencing Analysis of the db/db Mouse Hippocampus Reveals Cell-Type-Specific Insights Into the Pathobiology of Diabetes-Associated Cognitive Dysfunction

Frontiers in endocrinology (Lausanne), 2022-06, Vol.13, p.891039-891039

2022

Volltextzugriff (PDF)

Thyroid-stimulating hormone inhibits adipose triglyceride lipase in 3T3-L1 adipocytes through the PKA pathway

PloS one, 2015-01, Vol.10 (1), p.e0116439-e0116439

2015

Volltextzugriff (PDF)

Statin Use and Benefits of Thyroid Function: A Retrospective Cohort Study

Frontiers in endocrinology (Lausanne), 2021-03, Vol.12, p.578909-578909

2021

Volltextzugriff (PDF)

Plasma extrachromosomal circular DNA as a potential diagnostic biomarker for nodular thyroid disease

Clinical and translational medicine, 2024-06, Vol.14 (6), p.e1740-n/a

2024

Volltextzugriff (PDF)

TSH promotes adiposity by inhibiting the browning of white fat

Adipocyte, 2020-01, Vol.9 (1), p.264-278

2020

Volltextzugriff (PDF)

Gut dysbiosis is associated with primary hypothyroidism with interaction on gut-thyroid axis

Clinical science (1979), 2020-06, Vol.134 (12), p.1521-1535

2020

Volltextzugriff (PDF)

Association between Regional Body Muscle Mass and Non-Alcoholic Fatty Liver Disease: An Observational Study Using Data from the REACTION Study

Journal of personalized medicine, 2023-01, Vol.13 (2), p.209

2023

Volltextzugriff (PDF)

Physical Activity, Sedentary Behavior, and the Risk of Cardiovascular Disease in Type 2 Diabetes Mellitus Patients: The MIDiab Study

Engineering (Beijing, China), 2023-01, Vol.20 (1), p.26-35

2023

Volltextzugriff (PDF)

Thyroid stimulating hormone increases hepatic gluconeogenesis via CRTC2

Molecular and cellular endocrinology, 2017-05, Vol.446, p.70-80

2017

Volltextzugriff (PDF)

Expression of apelin‑13 and its negative correlation with TGF‑β1 in patients with diabetic kidney disease

Experimental and therapeutic medicine, 2024-03, Vol.27 (3), Article 110

2024

Volltextzugriff (PDF)

Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol

Cell research, 2019-02, Vol.29 (2), p.151-166

2019

Volltextzugriff (PDF)

Fenofibrate‐induced hepatotoxicity: A case with a special feature that is different from those in the LiverTox database

Journal of clinical pharmacy and therapeutics, 2020-02, Vol.45 (1), p.204-207

2020

Volltextzugriff (PDF)

Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro

Journal of inflammation research, 2020-01, Vol.13, p.533-542

2020

Volltextzugriff (PDF)

Transcription regulators and hormones involved in the development of brown fat and white fat browning: transcriptional and hormonal control of brown/beige fat development

Physiological research, 2018-01, Vol.67 (3), p.347-362

2018

Volltextzugriff (PDF)

Multifactorial Intervention on Type 2 Diabetes (MIDiab) Study: A multicenter, open‐label, randomized, parallel controlled, community trial

Journal of diabetes, 2020-11, Vol.12 (11), p.862-864

2020

Volltextzugriff (PDF)

SREBP-2, a new target of metformin?

Drug design, development and therapy, 2018-01, Vol.12, p.4163-4170

2018

Volltextzugriff (PDF)

Relationship between plasma 12,13-diHOME level and nonalcoholic fatty liver disease in patients with type 2 diabetes and obesity

Minerva Endocrinology, 2021-04

2021

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(56)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin‐3 level

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR

Association of Obesity based on Different Metabolic Status with Risk of Gout Occurrence in Patients: A National Study

The effect of G0S2 on insulin sensitivity: A proteomic analysis in a G0S2 -overexpressed high-fat diet mouse model

The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP/PS1 mice

Thyrotropin and obesity: increased adipose triglyceride content through glycerol-3-phosphate acyltransferase 3

Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Gynostemma pentaphylla (Thunb.) Makino treated mice

Exploring the link between obesity and hypothyroidism in autoimmune thyroid diseases: a metabolic perspective

Single-Cell Sequencing Analysis of the db/db Mouse Hippocampus Reveals Cell-Type-Specific Insights Into the Pathobiology of Diabetes-Associated Cognitive Dysfunction

Thyroid-stimulating hormone inhibits adipose triglyceride lipase in 3T3-L1 adipocytes through the PKA pathway

Statin Use and Benefits of Thyroid Function: A Retrospective Cohort Study

Plasma extrachromosomal circular DNA as a potential diagnostic biomarker for nodular thyroid disease

TSH promotes adiposity by inhibiting the browning of white fat

Gut dysbiosis is associated with primary hypothyroidism with interaction on gut-thyroid axis

Association between Regional Body Muscle Mass and Non-Alcoholic Fatty Liver Disease: An Observational Study Using Data from the REACTION Study

Physical Activity, Sedentary Behavior, and the Risk of Cardiovascular Disease in Type 2 Diabetes Mellitus Patients: The MIDiab Study

Thyroid stimulating hormone increases hepatic gluconeogenesis via CRTC2

Expression of apelin‑13 and its negative correlation with TGF‑β1 in patients with diabetic kidney disease

Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol

Fenofibrate‐induced hepatotoxicity: A case with a special feature that is different from those in the LiverTox database

Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro

Transcription regulators and hormones involved in the development of brown fat and white fat browning: transcriptional and hormonal control of brown/beige fat development

Multifactorial Intervention on Type 2 Diabetes (MIDiab) Study: A multicenter, open‐label, randomized, parallel controlled, community trial

SREBP-2, a new target of metformin?

Relationship between plasma 12,13-diHOME level and nonalcoholic fatty liver disease in patients with type 2 diabetes and obesity

Suchergebnisse filtern